![]() |
市場調查報告書
商品編碼
2070546
熱稀釋導管市場:規模、佔有率、成長、全球產業分析、區域趨勢及2026-2034年預測Thermodilution Catheter Market Size, Share, Growth, Global Industry Analysis, Regional Insights and Forecast to 2026-2034 |
||||||
全球熱稀釋導管市場預計在2025年達到6.291億美元,並從2026年的6.599億美元成長至2034年的10.194億美元,預測期內複合年成長率(CAGR)為5.6%。市場擴張的主要促進因素包括心血管疾病盛行率的上升、心血管手術的增加、微創監測技術的廣泛應用以及重症監護技術的持續進步。北美正在崛起成為重要的區域市場,預計到2025年將佔全球銷售額的36.85%。
熱稀釋導管是一種專門用於測量重症患者心摶出量和監測血流動力學參數的診斷設備。這些導管在加護病房(ICU)、手術室和心臟外科中心發揮著至關重要的作用,因為在這些場所,準確評估心臟功能至關重要。對病患監測日益成長的需求以及對改善臨床療效的期望,持續推動全球市場的成長。
主要市場趨勢
影響熱稀釋導管市場的最顯著趨勢之一是從傳統監測系統轉向先進的數位血流動力學監測平台的轉變。醫療機構正擴大採用整合解決方案,以實現連續監測、自動分析、無線數據傳輸以及與醫院資訊系統的無縫整合。
此外,醫院正增加對人工智慧驅動的監測系統的投入,這些系統能夠提供預測性訊息,使臨床醫生能夠更早發現併發症並改善治療效果。這些創新也提高了導管的準確性、效率和易用性。
市場促進因素
心血管手術量的增加正在推動市場成長。
隨著全球心臟病發生率的上升,需要進行高階血流動力學監測的心血管手術數量也增加。熱稀釋導管廣泛應用於心血管手術和重症監護管理中,用於評估心摶出量和血液循環。
加護病房收治的患者數量不斷增加,以及對精確心血管監測的需求不斷成長,推動了全球對熱稀釋導管系統的持續強勁需求。
市場限制因素
高昂的設備成本阻礙了設備的普及。
儘管熱稀釋導管系統具有許多臨床優勢,但需要對設備、監測平台和人員培訓進行大量投資。在中小型醫療機構中,預算限制往往限制了這個系統的應用。
在開發中國家,醫療服務提供者往往優先考慮基本醫療設備,而不是先進的監測技術,這減緩了市場滲透速度。
市場機遇
人工智慧驅動的智慧監控系統正在開闢新的成長途徑。
醫療產業正在迅速向智慧監控平台轉型,這些平台可以整合人工智慧、預測分析和基於雲端的資料管理。
開發具備自動化決策支援功能的智慧熱稀釋導管解決方案的製造商有望從這一趨勢中獲益匪淺。與電子健康記錄和遠端患者監護平台的整合將進一步提升其未來的成長前景。
市場挑戰
熟練人員短缺
有效使用熱稀釋導管需要專業的臨床知識。導管插入、資料解讀和病患管理都需要訓練有素的醫護人員。
人員短缺、培訓成本上升以及技術複雜性不斷增加,這些仍然是營運方面的挑戰,尤其是對於小規模的醫療機構。
材料
到2025年,聚氨酯導管憑藉其優異的柔軟性、耐用性、安全性和抗扭曲性,將佔市場主導地位。此外,聚氨酯導管適用於長期病患監測。
預計到 2034 年,矽酮產業的複合年成長率將達到 5.8%。
用途別
到2025年,血流動力學監測領域將佔最大的市場佔有率。重症患者對持續心血管監測的需求日益成長,推動了基於熱稀釋法的監測系統的需求。
預計在預測期內,重症監護和休克管理領域的複合年成長率將達到 6.4%。
最終用戶
醫院和門診手術中心(ASC)憑藉其龐大的手術量和先進的監測基礎設施,成為市場成長的主要驅動力。預計到2026年,該細分市場將佔全球市場的61.8%。
預計在預測期內,專科診所細分市場將以 6.2% 的複合年成長率成長。
北美洲
北美仍然是最大的區域市場,預計到 2025 年將達到 2.318 億美元。這一成長是由心血管手術的增加、微創技術的普及以及強大的醫療保健基礎設施所推動的。
預計到 2026 年,美國市場規模將達到約 2.069 億美元,佔全球整體銷售額的近 31.3%。
歐洲
預計2026年,歐洲市場規模將達到1.795億美元,複合年成長率為5.0%。健全的醫療保健體系和主要醫療設備製造商的存在將繼續支撐市場擴張。
亞太地區
預計到 2026 年,亞太地區的市場規模將達到 1.783 億美元。醫療保健領域的投資增加、醫院基礎設施的擴建以及心血管疾病盛行率的上升正在推動該地區的需求。
拉丁美洲、中東和非洲
由於醫療保健的現代化和人們對先進心血管監測技術的認知不斷提高,預計這些地區將經歷穩步成長。
近期產業趨勢包括BD公司於2025年4月推出「HemoSphere Alta」平台,融合了預測性人工智慧技術,可進行先進的血流動力學監測。此外,Teleflex公司也於2025年透過收購Biotronic公司的血管介入業務,進一步鞏固了其市場地位。
The global thermodilution catheter market was valued at USD 629.1 million in 2025 and is projected to grow from USD 659.9 million in 2026 to USD 1,019.4 million by 2034, registering a CAGR of 5.6% during the forecast period. The market expansion is primarily driven by the increasing prevalence of cardiovascular diseases, growing volume of cardiac surgeries, rising adoption of minimally invasive monitoring procedures, and continuous advancements in critical care technologies. North America emerged as the leading regional market, accounting for 36.85% of global revenue in 2025.
Thermodilution catheters are specialized diagnostic devices used to measure cardiac output and monitor hemodynamic parameters in critically ill patients. These catheters play an essential role in intensive care units (ICUs), operating rooms, and cardiac surgery centers where accurate assessment of heart performance is required. Growing demand for real-time patient monitoring and enhanced clinical outcomes continues to support market growth worldwide.
Key Market Trends
One of the most significant trends influencing the thermodilution catheter market is the transition from conventional monitoring systems to advanced digital hemodynamic monitoring platforms. Healthcare providers are increasingly adopting integrated solutions capable of continuous monitoring, automated analysis, wireless data transfer, and seamless integration with hospital information systems.
Additionally, hospitals are investing in AI-enabled monitoring systems that provide predictive insights, helping clinicians detect complications earlier and improve treatment outcomes. These innovations are enhancing catheter accuracy, efficiency, and ease of use.
Market Drivers
Rising Cardiovascular Surgeries Fuel Market Growth
The increasing prevalence of heart diseases worldwide has led to a growing number of cardiovascular procedures requiring advanced hemodynamic monitoring. Thermodilution catheters are widely used during cardiac surgeries and critical care management to assess cardiac output and blood circulation.
Growing numbers of intensive care admissions and demand for accurate cardiovascular monitoring continue to create strong demand for thermodilution catheter systems globally.
Market Restraints
High Equipment Costs Restrict Adoption
Despite their clinical advantages, thermodilution catheter systems require significant investment in equipment, monitoring platforms, and staff training. Small and mid-sized healthcare facilities often face budget constraints that limit adoption.
In developing countries, healthcare providers frequently prioritize essential medical equipment over advanced monitoring technologies, slowing market penetration.
Market Opportunities
AI-Powered Smart Monitoring Systems Create New Growth Avenues
The healthcare industry is rapidly moving toward intelligent monitoring platforms capable of integrating artificial intelligence, predictive analytics, and cloud-based data management.
Manufacturers developing smart thermodilution catheter solutions with automated decision-support capabilities are expected to benefit significantly from this trend. Integration with electronic medical records and remote patient monitoring platforms further enhances future growth prospects.
Market Challenges
Skilled Workforce Shortages
Successful use of thermodilution catheters requires specialized clinical expertise. Catheter insertion, data interpretation, and patient management demand highly trained healthcare professionals.
Staff shortages, rising training costs, and increasing technological complexity continue to present operational challenges, particularly for smaller healthcare institutions.
By Material
The polyurethane segment dominated the market in 2025 due to its superior flexibility, durability, safety, and resistance to kinking. Polyurethane catheters also provide extended usability during long-term patient monitoring.
The silicone segment is expected to register a CAGR of 5.8% through 2034.
By Application
The hemodynamic monitoring segment held the largest market share in 2025. The growing need for continuous cardiovascular monitoring in critically ill patients has increased demand for thermodilution-based monitoring systems.
The critical care & shock management segment is anticipated to grow at a CAGR of 6.4% during the forecast period.
By End User
Hospitals and Ambulatory Surgical Centers (ASCs) dominated the market due to high procedure volumes and advanced monitoring infrastructure. The segment is expected to account for 61.8% of the global market in 2026.
The specialty clinics segment is projected to grow at a CAGR of 6.2% during the forecast period.
North America
North America remained the largest regional market, reaching USD 231.8 million in 2025. Growth is supported by increasing cardiac procedures, widespread adoption of minimally invasive technologies, and strong healthcare infrastructure.
The U.S. market is expected to reach approximately USD 206.9 million in 2026, representing nearly 31.3% of global revenue.
Europe
Europe is projected to reach USD 179.5 million in 2026, growing at a CAGR of 5.0%. Strong healthcare systems and the presence of major medical device manufacturers continue to support market expansion.
Asia Pacific
Asia Pacific is expected to reach USD 178.3 million in 2026. Rising healthcare investments, expanding hospital infrastructure, and growing cardiovascular disease prevalence are driving regional demand.
Latin America and Middle East & Africa
These regions are anticipated to witness steady growth due to healthcare modernization and increasing awareness of advanced cardiovascular monitoring technologies.
Competitive Landscape
The global thermodilution catheter market is semi-consolidated, with leading companies focusing on product innovation, acquisitions, and strategic partnerships.
Key market participants include:
Recent industry developments include the launch of BD's HemoSphere Alta platform in April 2025, which incorporates predictive AI technology for advanced hemodynamic monitoring. Teleflex also strengthened its market position through the acquisition of Biotronik's vascular intervention business in 2025.
Conclusion
The thermodilution catheter market is positioned for steady growth through 2034, supported by rising cardiovascular disease prevalence, increasing cardiac surgeries, and growing demand for advanced hemodynamic monitoring solutions. The market is expected to expand from USD 629.1 million in 2025 to USD 659.9 million in 2026, ultimately reaching USD 1,019.4 million by 2034. Technological advancements such as AI-powered monitoring platforms, digital integration, and improved catheter materials will continue to enhance clinical outcomes and drive future market adoption. North America is expected to maintain its leadership position, while Asia Pacific is projected to emerge as a high-growth region due to expanding healthcare infrastructure and increasing investment in critical care services.
Segmentation By Material, Application, End-User, and Region
By Material * Polyurethane
By Application * Hemodynamic Monitoring
By End-User * Hospitals & ASCs
By Region * North America (By Material, Application, End-User, and Country)